西部中医药
西部中醫藥
서부중의약
GANSU JOURNAL OF TRADITIONAL CHINESE MEDICINE
2014年
3期
5-6
,共2页
心绞痛,冠心病%内皮功能%总胆固醇%丹红注射液
心絞痛,冠心病%內皮功能%總膽固醇%丹紅註射液
심교통,관심병%내피공능%총담고순%단홍주사액
angina pectoris,coronary heartdisease%endothelialfunction%totalcholesterol%DanHong injection
目的：观察丹红注射液对冠心病心绞痛患者临床症状、内皮功能及血总胆固醇改善情况。方法：将冠心病心绞痛患者60例随机分为对照组和丹红组各30例，对照组予西药常规治疗，丹红组在对照组治疗的基础上加用丹红注射液治疗。结果：丹红组症状改善的总有效率为90.0%，明显优于对照组的66.7%（P＜0.05）；治疗后丹红组血总胆固醇含量（4.64±0.91）mmol/L明显低于对照组的（5.30±0.83）mmol/L（P＜0.01），治疗后丹红组的内皮素（46.61±6.87）pg/L亦明显低于对照组（52.96±5.85）pg/L（P＜0.01）。结论：丹红注射液能明显改善冠心病心绞痛患者的临床症状，降低其血总胆固醇含量，改善内皮功能。
目的：觀察丹紅註射液對冠心病心絞痛患者臨床癥狀、內皮功能及血總膽固醇改善情況。方法：將冠心病心絞痛患者60例隨機分為對照組和丹紅組各30例，對照組予西藥常規治療，丹紅組在對照組治療的基礎上加用丹紅註射液治療。結果：丹紅組癥狀改善的總有效率為90.0%，明顯優于對照組的66.7%（P＜0.05）；治療後丹紅組血總膽固醇含量（4.64±0.91）mmol/L明顯低于對照組的（5.30±0.83）mmol/L（P＜0.01），治療後丹紅組的內皮素（46.61±6.87）pg/L亦明顯低于對照組（52.96±5.85）pg/L（P＜0.01）。結論：丹紅註射液能明顯改善冠心病心絞痛患者的臨床癥狀，降低其血總膽固醇含量，改善內皮功能。
목적：관찰단홍주사액대관심병심교통환자림상증상、내피공능급혈총담고순개선정황。방법：장관심병심교통환자60례수궤분위대조조화단홍조각30례，대조조여서약상규치료，단홍조재대조조치료적기출상가용단홍주사액치료。결과：단홍조증상개선적총유효솔위90.0%，명현우우대조조적66.7%（P＜0.05）；치료후단홍조혈총담고순함량（4.64±0.91）mmol/L명현저우대조조적（5.30±0.83）mmol/L（P＜0.01），치료후단홍조적내피소（46.61±6.87）pg/L역명현저우대조조（52.96±5.85）pg/L（P＜0.01）。결론：단홍주사액능명현개선관심병심교통환자적림상증상，강저기혈총담고순함량，개선내피공능。
Objective: To observe the effects of DanHong injection on im proving clinical symptoms , endothelial function and total cholesterol (TC ) in the serum of the patients with coronary heart disease angina pectoris. Methods: All 60 patients were randomized into the control group and Danhong group, the control group received Western medicine,DanHong group were given with DanHong injection on the foundation of the treatm ent given to the controlgroup.Results:Total effective rate of Dan Hong group was 90.0% ,obviously superior to 66.7% of the control group (P<0.05); TC contents of Danhong group after treating were (4.64±0.91)mmol/L ,evidently lower than (5.30±0.83)mmol/L of the controlgroup (P<0.01),the contents of endothelin in DanHong group were (46.61±6.87)pg/L aftertreating,rem arkably lower than (52.96±5.85)pg/L of the control group(P<0.01).Conclusion: DanHong injection could notably improve clinical symptoms of the patients suffering from coronary heart disease angina pectoris,reduce the contents of TC in the serum and improve endothelialfunction.
